Recombinant multi-species LC3A/MAP1LC3A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LC3A/MAP1LC3A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. The expression of variant 1 is suppressed in many tumor cell lines, suggesting that may be involved in carcinogenesis. [provided by RefSeq, Feb 2012]
The Alternative Names of target: 1010001H21Rik,4922501H04Rik,ATG8E,Autophagy-related protein LC3 A,Autophagy-related ubiquitin-like modifier LC3 A,LC3,LC3-I,LC3-II,LC3A,LC3a,MAP1 light chain 3-like protein 1,MAP1A/MAP1B light chain 3 A),MAP1ALC3,MAP1BLC3,MAP1LC3A,Map1lc3a,Microtubule-associated protein 1 light chain 3 alpha,Microtubule-associated proteins 1A/1B light chain 3A (MAP1A/MAP1B LC3 A

Target products collectionGo to LC3A/MAP1LC3A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12966-Ag-1/ GM-Tg-hg-IP12966-Ag-2 Human LC3A/MAP1LC3A protein Human
GM-Tg-rg-IP12966-Ag-1/ GM-Tg-rg-IP12966-Ag-2 Rat LC3A/MAP1LC3A protein Rat
GM-Tg-mg-IP12966-Ag-1/ GM-Tg-mg-IP12966-Ag-2 Mouse LC3A/MAP1LC3A protein Mouse
GM-Tg-cynog-IP12966-Ag-1/ GM-Tg-cynog-IP12966-Ag-2 Cynomolgus/Rhesus macaque LC3A/MAP1LC3A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12966-Ag-1/ GM-Tg-felg-IP12966-Ag-2 Feline LC3A/MAP1LC3A protein Feline
GM-Tg-cang-IP12966-Ag-1/ GM-Tg-cang-IP12966-Ag-2 Canine LC3A/MAP1LC3A protein Canine
GM-Tg-bovg-IP12966-Ag-1/ GM-Tg-bovg-IP12966-Ag-2 Bovine LC3A/MAP1LC3A protein Bovine
GM-Tg-equg-IP12966-Ag-1/ GM-Tg-equg-IP12966-Ag-2 Equine LC3A/MAP1LC3A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12966-Ag-1/ GM-Tg-hg-IP12966-Ag-2; GM-Tg-rg-IP12966-Ag-1/ GM-Tg-rg-IP12966-Ag-2;
GM-Tg-mg-IP12966-Ag-1/ GM-Tg-mg-IP12966-Ag-2; GM-Tg-cynog-IP12966-Ag-1/ GM-Tg-cynog-IP12966-Ag-2;
GM-Tg-felg-IP12966-Ag-1/ GM-Tg-felg-IP12966-Ag-2; GM-Tg-cang-IP12966-Ag-1/ GM-Tg-cang-IP12966-Ag-2;
GM-Tg-bovg-IP12966-Ag-1/ GM-Tg-bovg-IP12966-Ag-2; GM-Tg-equg-IP12966-Ag-1/ GM-Tg-equg-IP12966-Ag-2
Products Name LC3A/MAP1LC3A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name LC3A/MAP1LC3A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LC3A/MAP1LC3A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.